| abstract |
The present invention provides a novel compound having an NPY Y5 receptor antagonistic action. Formula (I) [Where: A is a substituted or unsubstituted hydrocarbon cyclic group or a substituted or unsubstituted heterocyclic group, X is N or CR 2 (R 2 is hydroxy, cyano, halogen, alkyl, alkoxy, alkylcarbonyl, heterocyclylcarbonyl or carbamoyl); Y is N or CH; R 1 is hydrogen or substituted or unsubstituted alkyl; B is a substituted hydrocarbon cyclic group or a substituted heterocyclic group. Or a pharmaceutically acceptable salt or solvate thereof. [Selection figure] None |